Gene-Specific Cancer Associations and Sensitivity of Genetic Testing Criteria with Holly LaDuca, MS, CGC

  • The content of this webinar is primarily based on a recent publication involving a large laboratory-based multigene panel cohort. First, gene-specific cancer risk associations will be presented, which were derived from comparing multigene panel testing cases to reference controls from gnomAD. Next, the attendee will be navigated through the prevalence of pathogenic variants among different clinical testing indications. Finally, the sensitivity of BRCA1/2 and Lynch syndrome testing criteria will be explored, with a focus on opportunities to improve upon identification of individuals with cancer-predisposing germline variants. 

Sr. Manager, Clinical Affairs Research


Register Now
  • Wed, January 15, 2020
  • 10:00am PST
  • Duration: 1 hour
  • C.E.U. --
  • P.A.C.E. --

Webinar Newsletter

Subscribe to receive notifications for future webinars.

Search Results

Start your search...